14 completed, 1 unknown. 15 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 15 | Completed 14, Unknown 1 |
Follow Edaravone: new trials by email Literature Review of Edaravone trials Research Report on Edaravone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects TTYP01, Radicava, Radicava ORS - Healthy Adult Subjects | Phase 1 | Completed | Shanghai Auzone Biological Technology Co., Ltd. | 29 | 2023-11-07 | 2026-04-24 |
| Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube MT-1186 - Healthy Adult Subjects | Phase 1 | Completed | Shionogi | 36 | 2021-02-26 | 2026-07-15 |
| A Study of TTYP01 in Healthy Adult Subjects TTYP01 single ascending doses, Placebo, TTYP01, 60 mg - Healthy Adult Subjects | Phase 1 | Completed | Shanghai Auzone Biological Technology Co., Ltd. | 72 | 2020-04-24 | 2025-01-06 |
| Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy MT-1186 - Japanese Patients With ALS | Phase 1 | Completed | Shionogi | 6 | 2020-01-24 | 2026-07-16 |
| Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study) MT-1186 - Healthy Adult Subjects | Phase 1 | Completed | Shionogi | 16 | 2019-06-10 | 2026-07-15 |
| Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection Compound Edaravone Injection, Edaravone Injection, 2-Aminoethanesulfonic Acid Injection - Drug-drug Interaction | Phase 1 | Completed | Nanjing Yoko Biomedical Co., Ltd. | 24 | 2019-05-10 | 2021-03-22 |
| Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis MT-1186 - Japanese Patients With ALS | Phase 1 | Completed | Shionogi | 9 | 2019-04-17 | 2026-07-15 |
| Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects MT-1186, MCI-186 - Healthy Adult Subjects | Phase 1 | Completed | Shionogi | 42 | 2019-03-22 | 2026-07-15 |
| PK Study in Subjects With Severe Hepatic Impairment MCI-186 - Severe Hepatic Impairment, Healthy | Phase 1 | Completed | Shionogi | 12 | 2018-11-06 | 2026-07-15 |
| Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study) MT-1186, Rosuvastatin, Sildenafil - Healthy Adult Subjects | Phase 1 | Completed | Shionogi | 84 | 2018-10-17 | 2026-07-15 |
| A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects MCI-186, Placebo - Healthy Adult Subjects | Phase 1 | Completed | Shionogi | 27 | 2018-09-18 | 2026-07-15 |
| Study of Oral Edaravone in Healthy Adult Males MT-1186, MT-1186-matching placebo - Healthy Adult Subjects | Phase 1 | Completed | Shionogi | 74 | 2018-03-20 | 2026-07-16 |
| Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment MCI-186 - Hepatic Impairment, Healthy | Phase 1 | Completed | Shionogi | 22 | 2016-11-16 | 2026-07-15 |
| Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment MCI-186 - Renal Impairment, Healthy | Phase 1 | Completed | Shionogi | 30 | 2016-10-27 | 2026-07-15 |
| Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke autologous hematopoiesis stem cell transplantation, Aspirin, Warfarin - Stroke | Phase 1 | Unknown | Zhejiang Hospital | 40 | 2012-01-01 | 2012-01-25 |
Renal Insufficiency (1) · Stroke (1)
Shionogi (11) · Shanghai Auzone Biological Technology Co., Ltd. (2) · Nanjing Yoko Biomedical Co., Ltd. (1) · Zhejiang Hospital (1)
Japan (10) · China (2) · Australia (1) · Czechia (1) · Hungary (1) · Slovakia (1) · United States (1)
Robert. Bass, MD (1) · Sepehr Shakib, MD (1) · Yaguo Li, master (1) · Yumiao Zhou, master (1)
PMID 36376130, PMID 32800532, PMID 33704925, PMID 37953075, PMID 32543120, PMID 32868037, PMID 33955162, PMID 36225132
2018 (1)